Sounds promising, at the beginning of the interview she mentions "Dimerix have sophisticated technology to look at re-purposing existing drugs into new therapies" could anyone shine some light in what this process actually is?
Thanks in advance
Sounds promising, at the beginning of the interview she mentions...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.030(6.67%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 41.8¢ | $656.5K | 1.534M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 116887 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 86738 | 6 |
View Market Depth
| Last trade - 12.39pm 02/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |